Asymptomatic eosinophilia is a common finding in returning travelers
and immigrants from parasite-endemic areas. We present a 49-year-old
man from Guyana who immigrated to the United States 4 years prior
to examination. He had persistent asymptomatic eosinophilia, and multiple
stool examinations were negative for ova and parasites. Although the
list of parasitic diseases associated with eosinophilia is extensive,
the differential diagnosis of asymptomatic eosinophilia with negative
stool evaluations is rather limited. We discuss herein elements of
the clinical history and examination essential for evaluating eosinophilia
in patients at risk of parasitic diseases and present a simple algorithm
to guide diagnostic testing. Despite the importance of repeated stool
examinations for the presence of ova and parasites, in practice this
test is not sensitive. Serologic testing for chronic parasitic infections
is often necessary. Most cases without a definitive diagnosis can
be conservatively managed with serial monitoring or empirically treated
with antihelminthic therapy, but patients with an absolute eosinophil
count of more than 3000/μL or more than 1500/μL for more than
6 months are at risk of end organ damage and should be referred for
specialized parasitic and/or hematology consultation.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Purchase Online Access to this article for 24 hours
Country-Specific Mortality and Growth Failure in Infancy and Yound Children and
Association With Material Stature
Use interactive graphics and maps to view and sort country-specific infant and early
dhildhood mortality and growth failure data and their association with maternal
Thank you for submitting a comment on this article. It will be reviewed by JAMA editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest*
Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 3
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
and access these and other features:
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.